Evidence map›Paper›PMID 25324544›Full record

ArticleThe Journal of biological chemistry2014

β-Apo-13-carotenone regulates retinoid X receptor transcriptional activity through tetramerization of the receptor.

Jian Sun, Sureshbabu Narayanasamy, Robert W Curley, Earl H Harrison

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Interplay between β-carotene and lipoprotein metabolism at the maternal-fetal barrier.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
  9. Apocarotenoids: Emerging Roles in Mammals.Annual review of nutrition · 2018
    Article
  10. Retinoid X Receptor Antagonists.International journal of molecular sciences · 2018
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jian SunFrom the Department of Human Sciences and.
Sureshbabu NarayanasamyFrom the Department of Human Sciences and College of Pharmacy, Ohio State University, Columbus, Ohio 43210.
Robert W CurleyCollege of Pharmacy, Ohio State University, Columbus, Ohio 43210.
Earl H HarrisonFrom the Department of Human Sciences and harrison.304@osu.edu.
The Ohio State University · US

Funding

DIETARY CAROTENOIDS--TRANSPORT IN HUMAN PLASMAR01HL049879 · NHLBI · U.S. DEPARTMENT OF AGRICULTURE · PI HARRISON, EARL HOWARD · 1994 to 2013
$2.5M
NHLBI NIH HHS R01 HL049879NHLBI NIH HHS R01-HL049879
6 · The paper itself

Abstract

Retinoid X receptor (RXRα) is activated by 9-cis-retinoic acid (9cRA) and regulates transcription as a homodimer or as a heterodimer with other nuclear receptors. We have previously demonstrated that β-apo-13-carotenone, an eccentric cleavage product of β-carotene, antagonizes the activation of RXRα by 9cRA in mammalian cells overexpressing this receptor. However, the molecular mechanism of β-apo-13-carotenone's modulation on the transcriptional activity of RXRα is not understood and is the subject of this report. We performed transactivation assays using full-length RXRα and reporter gene constructs (RXRE-Luc) transfected into COS-7 cells, and luciferase activity was examined. β-Apo-13-carotenone was compared with the RXRα antagonist UVI3003. The results showed that both β-apo-13-carotenone and UVI3003 shifted the dose-dependent RXRα activation by 9cRA. In contrast, the results of assays using a hybrid Gal4-DBD:RXRαLBD receptor reporter cell assay that detects 9cRA-induced coactivator binding to the ligand binding domain demonstrated that UVI3003 significantly inhibited 9cRA-induced coactivator binding to RXRαLBD, but β-apo-13-carotenone did not. However, both β-apo-13-carotenone and UVI3003 inhibited 9-cRA induction of caspase 9 gene expression in the mammary carcinoma cell line MCF-7. To resolve this apparent contradiction, we investigated the effect of β-apo-13-carotenone on the oligomeric state of purified recombinant RXRαLBD. β-Apo-13-carotenone induces tetramerization of the RXRαLBD, although UVI3003 had no effect on the oligomeric state. These observations suggest that β-apo-13-carotenone regulates RXRα transcriptional activity by inducing the formation of the "transcriptionally silent" RXRα tetramer.

Indexed as

AnimalsCarotenoidsCaspase 9Cell Line, TumorChlorocebus aethiopsCOS CellsCoumaric AcidsGene Expression Regulation, EnzymologicHumansMiceProtein MultimerizationRetinoid X Receptor alphaTetrahydronaphthalenesTranscription, Geneticbeta-apo-13-carotenoneCarotenoidsCASP9 protein, humanCasp9 protein, mouseCaspase 9Coumaric AcidsRetinoid X Receptor alphaTetrahydronaphthalenesUVI 3003ApocarotenoidCarotenoidNuclear ReceptorReceptor RegulationRetinoidTetramerizationVitamin A

Identifiers

PMID25324544
PMCPMC4246072
OpenAlexW1999446842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.